Hoeven Announces Over $200K in National Cancer Institute Funds for NDSU

WASHINGTON – Senator John Hoeven today announced that the National Cancer Institute has awarded a $211,568 grant to North Dakota State University (NDSU) for cancer treatment research. The research, directed by Dr. Katie Reindl of NDSU’s Biological Sciences Department, involves using a plant-based compound called piperlongumine to help fight cancer cells.

“North Dakota has enjoyed success in a wide variety of ways in recent years,” said Hoeven. “Our academic institutions have long served as a driver of that success, conducting research in areas of great value to our state, the nation and the world. Today’s award is part of our country’s wider investment in medical research, which supports improved and innovative treatments to combat disease and raise the quality of life for people around the globe.”

As a member of the U.S. Senate Appropriations Committee, Hoeven has worked to support research programs at the National Institutes of Health and joined a bipartisan letter to committee leaders last year to prioritize such programs in the annual appropriations bills.